Li Y X
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.
Zhonghua Zhong Liu Za Zhi. 1993 Nov;15(6):448-50.
Eleven of 605 (1.82%) patients evaluated at this Cancer Hospital for testicular germ cell malignancy between 1958 and 1992 had evidence of bilateral testicular malignancy. The age ranged from 28 to 72 years. Five patients had a history of undescended testes and one of them was surgically corrected at age of 11 years. Four of these were synchronous and seven metachronous. Histologically, all four synchronous tumors were pure seminoma. Two of seven metachronous tumor cases had unilateral testicular non-seminoma. The other 5 patients had pure seminoma. The second tumor was diagnosed between 8 months to 150 months after diagnosis of the first one. Three of 7 (42.9%) patients were diagnosed within 5 years. Two patients with synchronous tumors died within 1 year (3 months and 6 months, respectively). Only one patient with metachronous tumors died of the disease. This study indicates that the overall prognosis and outcome depends on the histologic type and stage of the disease and reemphasizes the low but definite risk for development of a second testicular malignancy.
1958年至1992年间,在这家癌症医院接受评估的605例睾丸生殖细胞恶性肿瘤患者中,有11例(1.82%)存在双侧睾丸恶性肿瘤的证据。年龄范围为28岁至72岁。5例患者有隐睾病史,其中1例在11岁时接受了手术矫正。其中4例为同时性肿瘤,7例为异时性肿瘤。组织学上,所有4例同时性肿瘤均为纯精原细胞瘤。7例异时性肿瘤病例中有2例为单侧睾丸非精原细胞瘤。其他5例患者为纯精原细胞瘤。第二个肿瘤在第一个肿瘤诊断后的8个月至150个月之间被诊断出来。7例(42.9%)患者中有3例在5年内被诊断出来。2例同时性肿瘤患者在1年内死亡(分别为3个月和6个月)。只有1例异时性肿瘤患者死于该疾病。这项研究表明,总体预后和结局取决于疾病的组织学类型和分期,并再次强调了发生第二个睾丸恶性肿瘤的风险虽低但确切存在。